LARIMAR THERAPEUTICS, INC.: cash_and_equivalents

Value{"amount": 27211000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2019-12-31)
Statussuperseded
EntityLARIMAR THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-20-008984 · Open the official SEC filing →
Retrieved: 2026-08-19T13:12:16.797926+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001374690/cash-and-equivalents/2019-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f287d146-7bb5-4db0-abcd-2e96881e6b2b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies